Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older
Clinical trial NCT02052596 · COMPLETED
Trial details
- NCT number
- NCT02052596
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-07
- Primary completion
- 2015-06-16
- Enrollment
- 935
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.